Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Uterine Neoplasms × palbociclib × Clear all

Sponsor

Conditions

Breast Neoplasms 54 Squamous Cell Carcinoma of Head and Neck 4 Sarcoma 4 Neoplasm Metastasis 4 Sarcoma, Ewing 3 Neoplasms 3 Medulloblastoma 3 Lymphoma, Non-Hodgkin 3 Glioma 3 Carcinoma, Non-Small-Cell Lung 3 Astrocytoma 3 Wilms Tumor 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Recurrence 2 Osteosarcoma 2 Oligodendroglioma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Lymphoma 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Glioblastoma 2 Ependymoma 2 Colonic Neoplasms 2 Xanthogranuloma, Juvenile 1 Triple Negative Breast Neoplasms 1 Testicular Neoplasms 1 Teratoma 1 Recurrent Squamous Cell Lung Carcinoma 1

Interventions

Paclitaxel 6 Radiotherapy 2 Pemetrexed 2 Carboplatin 2 Brachytherapy 2 tucatinib 1 seribantumab 1 osimertinib 1 gedatolisib 1 fosaprepitant 1 fluciclovine F-18 1 cobimetinib 1 atezolizumab 1 alovudine 1 Trastuzumab 1 Therapeutics 1 TP protocol 1 Saline Solution 1 Radiation 1 Protons 1 Palliative Care 1 Nivolumab 1 Letrozole 1 Immunoglobulin G 1 Imatinib Mesylate 1 Ifosfamide 1 Gemcitabine 1 Fulvestrant 1 FANG vaccine 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡